Table Of Contents:
Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
Chapter 3. Endometriosis Market: By Treatment Type Market Trends, Size, and Future Outlook
- By Treatment Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Treatment Type Definitions, Technology Landscape
- By Treatment Type Market Drivers
- Product Launches
- Technology Launches
- By Treatment Type Market Restraints
Chapter 4. Endometriosis Market: By Route of Administration Market Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
- Product Launches
- Technology Launches
- By Route of Administration Market Restraints
Chapter 5. Endometriosis Market: By Distribution Channel Market Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
Chapter 6. Endometriosis Market: By End-User Market Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
Chapter 7. Endometriosis Market: By Dosage Form Market Trends, Size, and Future Outlook
- By Dosage Form Market Size (US$), CAGR (%), and Forecast (2021-2031)
- By Dosage Form Definitions, Technology Landscape
- By Dosage Form Market Drivers
- Product Launches
- Technology Launches
- By Dosage Form Market Restraints
Chapter 8. Endometriosis Market: Regional Market Trends, Size, and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Product Launches
- Technology Launches
- Europe Market Restraints
- Competitive Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Product Launches
- Technology Launches
- Asia Pacific Market Restraints
- Competitive Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Product Launches
- Technology Launches
- Latin America Market Restraints
- Competitive Outlook
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2021-2031)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Product Launches
- Technology Launches
- Middle East & Africa Market Restraints
- Competitive Outlook
Endometriosis Market: Competitive Landscape
- Lupin Pharmaceuticals
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Symbiomix Therapeutics
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Starpharma Holdings
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Merck & Co.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Pfizer Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Novartis AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bayer AG
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sanofi
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- GlaxoSmithKline plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Johnson & Johnson
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Abbvie Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Gilead Sciences
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bristol-Myers Squibb Company
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Mylan N.V.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Allergan plc
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Cipla Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Aurobindo Pharma Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
Frequently Asked Questions
The current market size of the Endometriosis industry is approximately USD 1.8 billion.
Increasing prevalence of endometriosis, Rising awareness and diagnosis rates, Development of improved treatment options, Supportive government initiatives, Increasing healthcare expenditure, Favorable reimbursement policies, Growing focus on women's health, Advancements in diagnostic techniques, Increasing adoption of minimally invasive surgeries, Growing demand for personalized medicine.
Lack of definitive cure, High treatment costs, Delayed diagnosis and misdiagnosis, Lack of awareness and understanding, Side effects of existing treatments, Limited access to healthcare facilities in some regions, Stringent regulatory environment.
The leading component segment in the Endometriosis Market is the Hormonal Therapy segment, which includes various hormonal drugs for endometriosis treatment.
AbbVie, Bayer AG, Pfizer, Myovant Sciences, ObsEva SA, Ferring Pharmaceuticals, Takeda Pharmaceutical, Astellas Pharma, Kissei Pharmaceutical, Shionogi.
The Global Endometriosis Market is expected to reach US$ 3.8 Billion in 2031, registering a CAGR of 9.8% during the forecast period of 2024-2031.
Increasing prevalence of endometriosis, Rising awareness and diagnosis rates, Development of improved treatment options, Supportive government initiatives, Increasing healthcare expenditure, Growing demand for personalized medicine, Advancements in diagnostic techniques, Increasing adoption of minimally invasive surgeries.